Anagrelide Side Effects

Not all side effects for anagrelide may be reported. You should always consult a doctor or healthcare professional for medical advice. Side effects can be reported to the FDA here.

For the Consumer

Applies to anagrelide: oral capsule

In addition to its needed effects, some unwanted effects may be caused by anagrelide. In the event that any of these side effects do occur, they may require medical attention.

You should check with your doctor immediately if any of these side effects occur when taking anagrelide:

More common
  • Bloating or swelling of the face, arms, hands, lower legs, or feet
  • body aches or pain
  • burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings
  • chest pain
  • congestion
  • cough
  • difficult or labored breathing
  • dryness or soreness of the throat
  • fast, irregular, pounding, or racing heartbeat or pulse
  • fever
  • hoarseness
  • rapid weight gain
  • runny nose
  • tender, swollen glands in the neck
  • tightness in the chest
  • trouble with swallowing
  • voice changes
Less common
  • Anxiety
  • blurred vision
  • burning while urinating
  • chills
  • cold sweats
  • confusion
  • decreased urine output
  • dehydration
  • difficult or painful urination
  • dilated neck veins
  • dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position
  • extreme fatigue
  • general feeling of discomfort or illness
  • headache
  • irregular breathing
  • joint pain
  • large, flat, blue, or purplish patches in the skin
  • loss of appetite
  • muscle aches and pains
  • nausea or vomiting
  • noisy breathing
  • pale skin
  • redness of the face, neck, arms, and occasionally, upper chest
  • severe pain or pressure in the chest or the jaw, neck, back, or arms
  • sudden severe headache or weakness
  • swollen, painful, or tender lymph glands in the neck, armpit, or groin
  • trouble sleeping
  • troubled breathing with exertion
  • unusual bleeding or bruising
  • unusual tiredness or weakness
  • vomiting of blood or material that looks like coffee grounds
  • weight gain
Incidence not known
  • Abdominal or stomach pain or tenderness
  • clay colored stools
  • dark urine
  • decreased appetite
  • dry cough
  • general feeling of tiredness or weakness
  • rapid breathing
  • skin rash or itching
  • yellow eyes or skin

Some of the side effects that can occur with anagrelide may not need medical attention. As your body adjusts to the medicine during treatment these side effects may go away. Your health care professional may also be able to tell you about ways to reduce or prevent some of these side effects. If any of the following side effects continue, are bothersome or if you have any questions about them, check with your health care professional:

More common
  • Acid or sour stomach
  • back pain
  • belching
  • diarrhea
  • excess air or gas in the stomach or intestines
  • full feeling
  • general feeling of discomfort or illness
  • heartburn
  • hives or welts
  • indigestion
  • lack or loss of strength
  • pain
  • passing gas
  • stomach discomfort, upset, or pain
Less common
  • Burning feeling in the chest or stomach
  • change in vision
  • confusion
  • constipation
  • continuing ringing or buzzing or other unexplained noise in the ears
  • depression
  • difficulty with moving
  • double vision
  • hair loss or thinning of the hair
  • hearing loss
  • impaired vision
  • increased sensitivity of the skin to sunlight
  • leg cramps
  • loss of memory
  • muscle pain or stiffness
  • problems with memory
  • redness or other discoloration of the skin
  • seeing double
  • severe sunburn
  • sleepiness or unusual drowsiness
  • stuffy nose
  • swelling or inflammation of the mouth
  • swollen joints

For Healthcare Professionals

Applies to anagrelide: oral capsule

Nervous system

Very common (10% or more): Headache (43.5%), asthenia (23.1%), dizziness (15.4%), pain (15%)
Common (1% to 10%): Fever
Frequency not reported: Migraine, syncope, somnolence, confusion, insomnia, nervousness, amnesia

Cardiovascular

Very common (10% or more): Palpitations (26.1%)
Common (1% to 10%): Chest pain, tachycardia
Frequency not reported: Arrhythmia, cardiovascular disease, angina pectoris, heart failure, postural hypotension, thrombosis, vasodilation
Postmarketing reports: Torsades de pointes, ventricular tachycardia

Gastrointestinal

Very common (10% or more): Diarrhea (25.7%), nausea (17.1%), abdominal pain (16.4%), flatulence (10.2%)
Common (1% to 10%): Vomiting, anorexia, dyspepsia, constipation, gastritis, aphthous stomatitis, pharyngitis, hemorrhage, eructation, dehydration

General

Very common (10% or more): Edema (20.6%)
Common (1% to 10%): Peripheral edema
Frequency not reported: Tinnitus, flu symptoms, chills

Hematologic

Frequency not reported: Anemia, thrombocytopenia, ecchymosis, lymphadenopathy

Hepatic

Very rare (less than 0.01%): Cholestatic liver failure
Frequency not reported: Elevated liver enzymes

Musculoskeletal

Common (1% to 10%): Back pain
Frequency not reported: Arthralgia, myalgia, leg cramps

Respiratory

Very common (10% or more): Dyspnea (11.9%)
Frequency not reported: Pharyngitis, cough, rhinitis, epistaxis, respiratory disease, sinusitis, pneumonia, bronchitis, pleural effusion, pulmonary hypertension, pulmonary infiltrates, asthma, allergic alveolitis

Dermatologic

Common (1% to 10%): Rash (including urticaria)
Frequency not reported: Skin disease, alopecia, pruritus

Ocular

Frequency not reported: Photosensitivity, amblyopia, abnormal vision, visual field abnormality, diplopia

Genitourinary

Frequency not reported: Dysuria, hematuria

A 30-year-old man developed erectile dysfunction after 2 months of treatment with anagrelide which disappeared 2 weeks after stopping the drug. A definitive cause could not be determined.

Hypersensitivity

Very rare (less than 0.01%): A 60-year-old woman developed shortness of breath, palpitations, and chest pain after 1 week of treatment leading to respiratory failure and intubation by week 5. Patient recovered after treatment with methylprednisolone.
Frequency not reported: Severe hypersensitivity pneumonitis

The authors of the case report of severe hypersensitivity pneumonitis suggest that patients receiving anagrelide therapy, alone or in combination with hydroxyurea, may benefit from monitoring with serial chest X-rays, pulmonary function testing, and echocardiography to detect the development of cardiomyopathy or hypersensitivity pneumonitis.

Renal

Postmarketing reports: Tubulointerstitial nephritis.

Psychiatric

Frequency not reported: Depression

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate safety, effectiveness, or appropriateness for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of materials provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the substances you are taking, check with your doctor, nurse, or pharmacist.

Hide
(web1)